MENU
TGTX
Stock ticker: NASDAQ
PRICE
CHANGE
CAPITALIZATION
TG Therapeutics (TGTX) Ownership - Who owns TG Therapeutics?
Industry: @Biotechnology
Profile
Industry
Biotechnology
Address
3020 Carrington Mill boulevard
Phone
+1 212 554-4484
Employees
264
Web
https://www.tgtherapeutics.com
Details
Group
Domestic Stock Funds
Category
Biotechnology
Capitalization
5.23B
P/E Ratio
39.56
Total Cash
341.04M
Projected Growth
N/A
Total Debt
253.81M
Revenue
264.79M
Risk (Beta)
2.77
Dividend Yield
N/A
Total Cash/Share
2.19
Total Debt/Equity
0.21
Revenue/Share
1.66 USD as % of share price
Fundamentals
TGTX
Capitalization
5.23B
P/E Ratio
39.56
Risk (Beta)
2.77
Dividend Yield
N/A
Total Cash
341M
Total Cash/Share
2.19
Total Debt
254M
Total Debt/Equity
0.21
Projected Growth (PEG Ratio)
N/A
Revenue/Share (as % of the share price)
1.66%
Revenue
265M
ROE
N/A
Book Value
192M
P/B Ratio
27.17
Cash Flow
N/A
Earnings
-0.1
Average Daily Volume YTD
N/A
Common Shares Outstanding - Security Level
156K
Current Ratio
4.59
Current Revenue Per Employee
262943.56
Dividends Per Share - Security
N/A
EBITDA
5.82M
Float
N/A
Float - Current
N/A
Gross Income Margin
88.86
Revenue To Assets
-3.13
Shares Held By Institutions
3.36B
Shares Outstanding - Current
156M
Total Liabilities
394M
Total Volume MTD
N/A
Value
-1
Gain YTD
96.546
View a ticker or compare two or three
VS
VS
Show more...
Ad is loading...
A.I.Advisor
published price charts
A.I. Advisor
published General Information
General Information
a biopharmaceutical company
Industry Biotechnology
Profile
Fundamentals
Details
Industry
Biotechnology
Address
3020 Carrington Mill boulevard
Phone
+1 212 554-4484
Employees
264
Web
https://www.tgtherapeutics.com